Given the disproportionate impact of infectious diseases and AMR in low- and middle-income countries, marine AMPs offer sustainable, biocompatible, and potentially transformative alternatives for both human and veterinary medicine [9,24,25]. This evidence concerns the gene ADSL and infectious disease.